Morgan Stanley’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.1K | Sell |
16,608
-72,487
| -81% | -$26.6K | ﹤0.01% | 6980 |
|
|
2025
Q1 | $23.1K | Sell |
89,095
-331,342
| -79% | -$85.8K | ﹤0.01% | 6520 |
|
|
2024
Q4 | $237K | Sell |
420,437
-530,652
| -56% | -$299K | ﹤0.01% | 5722 |
|
|
2024
Q3 | $571K | Sell |
951,089
-322,474
| -25% | -$193K | ﹤0.01% | 5344 |
|
|
2024
Q2 | $3.44M | Buy |
1,273,563
+1,245,491
| +4,437% | +$3.36M | ﹤0.01% | 4185 |
|
|
2024
Q1 | $144K | Buy |
28,072
+21,218
| +310% | +$109K | ﹤0.01% | 5852 |
|
|
2023
Q4 | $3.68K | Buy |
6,854
+3,427
| +100% | +$1.84K | ﹤0.01% | 7050 |
|
|
2023
Q3 | $2.27K | Hold |
3,427
| – | – | ﹤0.01% | 7103 |
|
|
2023
Q2 | $5.21K | Sell |
3,427
-145,023
| -98% | -$220K | ﹤0.01% | 6979 |
|
|
2023
Q1 | $282K | Buy |
148,450
+148,335
| +128,987% | +$282K | ﹤0.01% | 5546 |
|
|
2022
Q4 | $109 | Hold |
115
| – | – | ﹤0.01% | 7690 |
|
|
2022
Q3 | $0 | Hold |
115
| – | – | ﹤0.01% | 7739 |
|
|
2022
Q2 | $0 | Sell |
115
-6,224
| -98% | – | ﹤0.01% | 7844 |
|
|
2022
Q1 | $16K | Sell |
6,339
-1,566
| -20% | -$3.95K | ﹤0.01% | 7228 |
|
|
2021
Q4 | $48K | Buy |
7,905
+6,325
| +400% | +$38.4K | ﹤0.01% | 6831 |
|
|
2021
Q3 | $12K | Buy |
+1,580
| New | +$12K | ﹤0.01% | 7267 |
|